What is a clinical trial? Is participating in a clinical trial right for you? Learn more
Cardiogenic Shock Clinical Trial in Paris
Have you or your loved ones been diagnosed with cardiogenic shock?
You may be eligible to participate in a cardiogenic shock clinical trial.
Have you or your loved ones been diagnosed with cardiogenic shock? You may be eligible to participate in a cardiogenic shock clinical trial.
Completed
Male & Female
18 Years +
A multicenter, prospective, controlled, randomized (moderate hypothermia 33°C≤ T°C ≤34°C) during 24 hours ± 1h versus normothermia (36°C≤ T°C ≤37°C), comparative open trial will be conducted on two parallel groups of patients with cardiogenic shock treated with VA-ECMO. The HYPO-ECMO trial will test the hypothesis that moderate hypothermia (temperature between 33°C≤ T°C ≤34°C) associated with VA-ECMO support results in a reduction in 30-day mortality in comparison with the normothermia group (36°C≤ T°C ≤37°C).